Macro Strategy - In October, China's exports showed a year-on-year decline of -1.10%, marking the first negative growth since March 2025, which affected the cumulative year-on-year growth rate, decreasing from 6.10% in September to 5.30% in October. This decline is attributed to a high base in October 2024 and a temporary escalation in trade conflicts between China and the US in early October 2025 [3][4]. Market Overview - From November 3 to November 7, 2025, A-share indices experienced wide fluctuations, with the Shanghai Composite Index rising by 1.08% and the ChiNext Index increasing by 0.65%. The market is expected to continue a "slow bull" trend with wide fluctuations in November due to reduced short-term trade conflict risks between China and the US [4][5]. - Among the 31 first-level industries, the top performers were electric equipment and coal, with weekly increases of 4.98% and 4.52%, respectively. Conversely, the beauty care and computer sectors saw declines of -3.10% and -2.54% [6][7]. North Exchange Market - As of November 7, 2025, the North Exchange had 282 listed stocks, with an average total market value of 908.24 billion yuan, reflecting a 1.24% increase from the previous week. The liquidity decreased, with average trading volume dropping by 17.23% [11][12]. - The highest weekly gain was recorded by Danna Biological, which surged by 377.78% in its first week of trading, while the largest decline was seen in Beiyikang, which fell by 12.35% [13]. Vaccine Industry - The vaccine industry is experiencing structural differentiation, with companies like Kangtai Biological and Zhonghui Biological making significant advancements in vaccine development for specific populations, such as infants and pregnant women. The updated technical guidelines emphasize the importance of vaccination for high-risk groups [17][21]. - The vaccine sector's performance remains under pressure, with a year-to-date decline of -1.57%. The industry is focusing on innovation and international expansion to navigate current challenges [19][21]. - The vaccine sector's price-to-earnings ratio (PE) is currently at 99.07X, reflecting a decrease of 4.97X from the previous week, while the price-to-book ratio (PB) remains stable at 1.94X [20]. Investment Recommendations - The vaccine industry is advised to focus on innovation and international markets, as the current market conditions present challenges due to supply-demand imbalances and intense competition. Companies with strong technological capabilities and differentiated product lines are recommended for investment [21][23].

Summary of Key Points Core Viewpoint - On October 29, Hangzhou Oxygen Plant Co., Ltd. disclosed an increase in shareholding, while 11 A-share listed companies announced plans for share reductions [1][2]. Group 1: Shareholding Increases - Hangzhou Oxygen Plant received a stake increase from CITIC Financial Assets, raising its holding to 5% [2]. Group 2: Shareholding Reductions - Greenfield Machinery: Shareholder Shao Yutian plans to reduce holdings by no more than 3% [2]. - Jianghua Micro: Shareholder Yin Fuhua intends to reduce holdings by no more than 3% [2]. - Jiuzhou Group: Shareholders plan to collectively reduce holdings by no more than 1.88% [2]. - Guorui Technology: Shareholder Gong Ruiliang plans to reduce holdings by no more than 3% [2]. - Kairun Co., Ltd.: Shareholder Li Zhongren plans to reduce holdings by no more than 1.70% [2]. - Yingjixin: Shareholder plans to transfer 2.9% of company shares through inquiry [2]. - Mindong Electric: Shareholder Provincial Investment Group intends to reduce holdings by no more than 1% [2]. - WuXi AppTec: Shareholders controlled by the actual controller plan to reduce holdings by no more than 2% [2]. - Zhongwei Company: A dedicated repurchase account plans to reduce holdings by no more than 0.33% [2]. - Jinhua Co., Ltd.: Plans to reduce no more than 746.54 million shares that have been repurchased [2]. - Hechuan Technology: Bosch China intends to reduce holdings by no more than 3% [2].

Core Viewpoint - The A-share market experienced a low opening but closed higher, with the Shanghai Composite Index rising by 0.45% to 3633.99 points, indicating a positive market sentiment despite some sector declines [1] Market Performance - The total trading volume for the Shanghai Composite Index was 707.22 billion yuan, while the Shenzhen Component Index reached 111.78 billion yuan with a 0.64% increase, and the ChiNext Index rose by 0.66% to 235.90 billion yuan [1] - Key sectors that performed well included military equipment, rubber products, and electric motors, while traditional medicine, chemical pharmaceuticals, and medical services saw declines [1] Sector Performance - Top performing sectors: - Military Equipment: Increased by 3.70% with a total trading volume of 443.77 million hands and a transaction value of 92.20 billion yuan [1] - Rubber Products: Increased by 2.91% with a trading volume of 25.79 million hands and a transaction value of 4.43 billion yuan [1] - Electric Motors: Increased by 2.32% with a trading volume of 58.83 million hands and a transaction value of 13.43 billion yuan [1] - Underperforming sectors: - Traditional Medicine: Decreased by 1.93% with a trading volume of 208.43 million hands and a transaction value of 20.74 billion yuan [1] - Chemical Pharmaceuticals: Decreased by 1.15% with a trading volume of 424.26 million hands and a transaction value of 67.13 billion yuan [1] - Medical Services: Decreased by 1.04% with a trading volume of 111.52 million hands and a transaction value of 24.91 billion yuan [1]

Market Overview - The A-share market showed mixed performance with the Shanghai Composite Index up by 0.20% to 3567.02 points, while the Shenzhen Component Index fell by 0.28% to 10960.75 points, and the ChiNext Index decreased by 0.49% to 2311.27 points [1] Sector Performance Top Performing Sectors - The military equipment sector led the gains with an increase of 3.57%, achieving a total trading volume of 1,709.77 million hands and a total transaction value of 405.32 billion [2] - The military electronics sector followed closely with a rise of 3.46%, with a trading volume of 871.19 million hands and a transaction value of 187.84 billion [2] - Precious metals also saw a gain of 3.46%, with a trading volume of 503.66 million hands and a transaction value of 91.12 billion [2] Underperforming Sectors - The pharmaceutical retail sector experienced the largest decline at -1.64%, with a trading volume of 331.83 million hands and a transaction value of 43.42 billion [2] - The medical services sector fell by 1.54%, with a trading volume of 741.96 million hands and a transaction value of 172.63 billion [2] - The chemical pharmaceuticals sector decreased by 1.46%, with a trading volume of 3,203.93 million hands and a transaction value of 475.94 billion [2]

Market Performance - A-shares steadily advanced this week, with the ChiNext Index reaching a new high for the year and the Shenzhen Component Index hitting a four-month high, approaching its highest point of the year [1] - Weekly trading volume increased to 7.73 trillion yuan, marking the largest weekly trading volume in three months [1] Fund Inflows - Leverage funds actively entered the market, with most industries under the Shenwan first-level industry classification seeing net buying, particularly the computer industry with over 4.4 billion yuan and the electronics industry with over 3 billion yuan [2] - The electronic, biopharmaceutical, and automotive sectors each received over 20 billion yuan in net inflows, while the non-bank financial sector saw a net outflow of over 8.3 billion yuan [2] Rare Earth Demand - The rare earth sector performed strongly, with the rare earth permanent magnet index reaching a three-and-a-half-year high [3] - Demand for rare earths is expected to grow rapidly due to advancements in humanoid robots and electric vehicles, with estimates suggesting a demand of at least 70,000 tons of neodymium-iron-boron by 2025 [3] Energy Metals - The energy metals sector, including lithium and cobalt, reached a two-year high, with lithium carbonate futures breaking 70,000 yuan/ton, marking a 20% increase from recent lows [4] - Short-term lithium salt supply may decline due to reduced exports from Chile and domestic production halts, leading to a potential price stabilization [4] Biopharmaceutical Sector - The biopharmaceutical sector saw significant gains, with the innovative drug index hitting record highs multiple times this week [6] - Notable stocks in the sector, such as Lianhuan Pharmaceutical and Aosaikang, experienced consecutive trading halts, with some stocks showing year-to-date gains exceeding 200% [6][7] Earnings Forecasts - Several pharmaceutical companies have recently forecasted substantial profit increases for the first half of 2025, with estimates suggesting net profit growth exceeding 19 times for some firms [7]

Investment Rating - The industry investment rating is "Outperform the Market," indicating an expected increase of over 10% in the industry index relative to the CSI 300 index over the next six months [14]. Core Insights - The A-share market experienced a slight decline on June 19, 2025, with the Shanghai Composite Index closing at 3362.11 points, down 0.79%. The market showed a mixed performance, with sectors like mining, oil, gas, and cultural media performing well, while software development, internet services, electronic components, and chemical pharmaceuticals lagged [2][6]. - The average price-to-earnings (P/E) ratios for the Shanghai Composite and ChiNext indices are 13.93 times and 37.00 times, respectively, which are at the median levels over the past three years, suggesting a favorable environment for medium to long-term investments [2][13]. - The market is expected to maintain a steady upward trend in the short term, with structural opportunities still present, particularly in sectors such as consumer electronics, communication equipment, semiconductors, and aerospace [2][13]. Summary by Sections A-share Market Overview - On June 19, 2025, the A-share market opened lower and experienced slight fluctuations, with the Shanghai Composite Index finding support around 3354 points. The market showed a general trend of minor fluctuations throughout the day, with significant trading volume of 12,810 billion yuan, above the median of the past three years [6][13]. - The performance of various sectors was mixed, with over 60% of stocks declining. Notable gainers included electronic components, optical electronics, consumer electronics, wind power equipment, and aerospace, while sectors like pesticides, beauty care, small metals, medical services, and pharmaceutical commerce saw significant declines [6][8]. Future Market Outlook and Investment Recommendations - The report anticipates a continued moderate recovery in the Chinese economy, driven by consumption and investment. The market expects the Federal Reserve to potentially lower interest rates as early as September, which may lead to further easing of overseas liquidity [2][13]. - Short-term investment opportunities are recommended in sectors such as consumer electronics, communication devices, semiconductors, and aerospace, while close attention should be paid to policy changes, funding conditions, and external market developments [2][13].